Zenas BioPharma, Inc. (ZBIO) stock
ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$23.85−1.19 (-4.75%)
Close on Nov 20, 2026Market cap $1.55BP/E –Yield –
Zenas BioPharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Zenas BioPharma's free cash flow for the twelve months ending Sep 30, 2026 was -$242.83M. For fiscal 2025 it was -$172.35M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$172.35M | – |
| FY2024 | Dec 31, 2024 | -$119.81M | – |
| FY2023 | Dec 31, 2023 | -$30.55M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$57.99M | – |
| Q2 FY2026 | Jun 30, 2026 | -$57.24M | – |
| Q1 FY2026 | Mar 31, 2026 | -$75.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$52.41M | – |
| Q3 FY2025 | Sep 30, 2025 | -$41.13M | – |
| Q2 FY2025 | Jun 30, 2025 | -$41.74M | – |
| Q1 FY2025 | Mar 31, 2025 | -$37.07M | – |
| Q4 FY2024 | Dec 31, 2024 | -$38.63M | – |
| Q3 FY2024 | Sep 30, 2024 | -$31.06M | – |
| Q2 FY2024 | Jun 30, 2024 | -$30.99M | – |
| Q1 FY2024 | Mar 31, 2024 | -$19.12M | – |
See a number that looks wrong?